Ignite Creation Date:
2025-12-26 @ 5:18 PM
Ignite Modification Date:
2026-01-22 @ 7:46 AM
Study NCT ID:
NCT00474006
Status:
COMPLETED
Last Update Posted:
2011-06-10
First Post:
2007-05-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML
Sponsor:
Cooperative Study Group A for Hematology
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
C-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
COSAH
Old Organization:
Cooperative Study Group A for Hematology